PTC596 clinical trials
Also written PTC596 and Unesbulin.
How each study uses PTC596 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 2
PTC Therapeutics (3) · Nationwide Children's Hospital (1) · University of Oklahoma (1)
Studies
Open first, then newest update. How each study uses PTC596 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade GliomaActive, not recruitingPhase 1Nationwide Children's HospitalNCT03605550Written as PTC596How we know
- A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)TerminatedPhase 2/3PTC TherapeuticsNCT05269355Written as UnesbulinHow we know
- Unesbulin in Women With Ovarian Cancer Receiving Neoadjuvant ChemotherapyCompletedPhase 1University of OklahomaNCT03206645Written as UnesbulinHow we know
- A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)CompletedPhase 1PTC TherapeuticsNCT03761095Written as UnesbulinHow we know
- PTC596 in Patients With Advanced Solid TumorsCompletedPhase 1PTC TherapeuticsNCT02404480Written as PTC596How we know